Related Experiment Videos

Fibrinolytic and mechanical intervention trials in ST elevation acute myocardial infarction

Thach Nguyen¹, Shigeru Saito, Pham Hoan Tien

¹Cardiac Catheterization Laboratories, Community Healthcare System, St. Mary Medical Center, 1500 South Lakepark Ave., Hobart, IN 46342, USA. thachnguyen2000@yahoo.com

Journal of Interventional Cardiology

|September 20, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Performance of the STS Risk Score in Predicting Outcomes in Impella-Supported High-Risk Percutaneous Coronary Intervention: Insights From the PROTECT III Study.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Persistent One-Year Mortality Gradient After STEMI and COVID-19: Long-Term Outcomes From the NACMI Registry.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Low-Density Lipoprotein Cholesterol Lowering With Inclisiran Plus Usual Care in Recent Acute Coronary Syndrome: VICTORION-INCEPTION, a Randomized, Controlled, Open-Label Trial.

Journal of the American Heart Association·2026

Baseline ECG Outperforms the Angiogram for Predicting Mortality in COVID-19-Associated STEMI: Insights From the NACMI Registry.

Journal of the Society for Cardiovascular Angiography & Interventions·2026

Clinical outcomes of aortic stenosis patients undergoing Impella-supported high-risk percutaneous coronary intervention.

Frontiers in cardiovascular medicine·2026

Short-Term Outcomes of Impella-Supported High-Risk Percutaneous Coronary Intervention in Surgically Ineligible Patients: Insights From PROTECT III.

Journal of the Society for Cardiovascular Angiography & Interventions·2025

See all related articles